US expands prescribing recommendations for aspirin

The US Food and Drug Administration (FDA) has substantially expanded its official prescribing recommendations and labelling requirements for aspirin to increase use in ischaemic heart disease and stroke.

The effectiveness of aspirin in preventing heart attacks and limiting infarct size is widely known, but only about half of patients who have had a heart attack receive the drug, according to an advisory panel. Under the new ruling, …